Erlonat 150 Erlonat 150 contains Erlotinib 150 mg, a targeted anti-cancer medicine used to treat cancers with specific EGFR mutations. It helps control the disease by blocking the signals that cancer cells need to grow and divide. By slowing the growth of these cells, Erlonat 150 supports long-term cancer management when prescribed by an oncologist.